Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
30%
Ph phase_3
3
30%
Ph phase_1
4
40%

Phase Distribution

4

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (40.0%)
Phase 23 (30.0%)
Phase 33 (30.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_1

Drug-drug Interaction Study of FYU-981 and Oxaprozin

NCT03350386
completedphase_3

Study of FYU-981 in Hyperuricemia With or Without Gout

NCT03006445
completedphase_3

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

NCT03100318
completedphase_3

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

NCT03372200
completedphase_1

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

NCT03375632
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03350386Phase 1

Drug-drug Interaction Study of FYU-981 and Oxaprozin

Completed
NCT03006445Phase 3

Study of FYU-981 in Hyperuricemia With or Without Gout

Completed
NCT03100318Phase 3

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Completed
NCT03372200Phase 3

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Completed
NCT03375632Phase 1

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

Completed
NCT03306667Phase 1

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

Completed
NCT02837198Phase 2

Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

Completed
NCT03350373Phase 1

Clinical Pharmacology of FYU-981 (Final Formulation)

Completed
NCT02515864Phase 2

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

Completed
NCT02416167Phase 2

Study of FYU-981 in Hyperuricemia With or Without Gout

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10